Skip to content

Microbiotica vs Microviable Therapeutics SL

Microbiotica  logo

Microbiotica

The microbiome is a new approach to medicine, offering potential for significant advancements. Microbiotica aims to remove translation challenges

49 employees · est. 2016 · Cambridge, United Kingdom

VS
Microviable Therapeutics SL logo

Microviable Therapeutics SL

Developing novel biological drugs based on the microbiome to address unmet challenges in human diseases

12 employees · est. 2016 · Gijon, Spain

Side-by-Side Comparison

Microbiotica Microviable Therapeutics SL
Founded
2016 2016
Headquarters
Cambridge, United Kingdom Gijon, Spain
Employees
49 12
Industry
Biotechnology, Health Care, Health and Wellness Health Care, Life Sciences
Funding Stage
Venture round Seed
Total Funding
$62.00M $1.50M
Funding Rounds
4 1
Services
Development and commercialization of clinic-ready defined live biotherapeutic products for immuno-oncology and inflammatory bowel disease Not tracked yet
Target Customers
Patients suffering from immuno-oncology and inflammatory bowel diseases, healthcare providers, pharmaceutical companies, and research institutions Not tracked yet
Taxonomy
MicrobiomeBiotechResearchClinical TrialsCancerOncology +6 BiotechMicrobiomeBiological DrugsInfectious DiseasesOncologyDermatology +9
Website
microbiotica.com microviable.com
Microbiotica  logo

About Microbiotica

Microbiotica is a biotechnology company founded in 2016, headquartered in the United Kingdom. The company focuses on leveraging the microbiome as a novel approach to medicine, aiming to address translation challenges in the field. With a background rooted in a decade-long investment at the Wellcome...

Microviable Therapeutics SL logo

About Microviable Therapeutics SL

Microviable Therapeutics SL is a biotech startup dedicated to developing novel biological drugs based on the microbiome to address unmet challenges in infectious diseases, oncology, and dermatology. The company's PharmaBiota® platform and proprietary technology have enabled the creation of two disti...

Also comparing in this category

Comparing more than these two?

Get Microbiotica , Microviable Therapeutics SL and up to nine more competitors side by side in one PDF: team, funding, traffic and every dated move of the last six months. Every company is re-checked on the day you order.

How does Microbiotica compare?

A PDF of Microbiotica and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Rival Readout

Comparing competitors? We do this properly.

10 rivals, 90 days of dated moves in 7 business days: a ranked list of what matters, each with its source, ending in a 60-minute readout with your team.

Frequently Asked Questions

Microbiotica was founded in 2016, based in Cambridge, United Kingdom, with 49 employees. Microbiotica is a biotechnology company founded in 2016, headquartered in the United Kingdom. The company focuses on leveraging the microbiome as a novel approach to medicine, aiming to address transl. Microviable Therapeutics SL was founded in 2016, based in Gijon, Spain, with 12 employees. Microviable Therapeutics SL is a biotech startup dedicated to developing novel biological drugs based on the microbiome to address unmet challenges in infectious diseases, oncology, and dermatology. T.
Microbiotica has raised $62.00M and Microviable Therapeutics SL $1.50M. Latest stage: Microbiotica Venture round, Microviable Therapeutics SL Seed.
Both work in Health Care and list microbiome, biotech and clinical trials among their focus areas.

Compare Microbiotica with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Microbiotica on 24 Feb 2025, and Microviable Therapeutics SL on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout